News Headlines Article

Lilly yanks millions from UCSD for Alzheimer’s study
San Diego Union-Tribune

Pharmaceutical giant Eli Lilly is shifting tens of millions of dollars from UC San Diego to the University of Southern California to test a drug on older people who have some evidence of Alzheimer’s disease but have yet to show symptoms.

The move represents a huge setback to UC San Diego in its legal fight with USC over control of the Alzheimer’s Disease Cooperative Study (ADCS), a nationwide effort to better diagnose and treat the disease.

Lilly said on Tuesday that it will move the money it planned to give UC San Diego for a clinical test of Lilly’s Alzheimer’s drug, solanezumab.